Clinical Proteomics encompasses all aspects of translational proteomics. This includes quantitative and qualitative profiling of proteins and peptides that are present in clinical specimens like human tissues and body fluids. Special emphasis is placed on the application of proteomic technology to all aspects of clinical research and molecular medicine.
 
As an open access journal, Clinical Proteomics is committed to rapid scientific review and timely publication of submitted manuscripts. This is achieved by receiving, processing and publishing submissions online. As molecular medicine moves beyond genomics to proteomics, the goal becomes the characterization of the cellular circuitry and the understanding of the impact of disease and therapy on precision medicine.
 
Clinical Proteomics provides a scholarly forum for novel scientific research in the field of translational proteomics. The journal is publishing manuscripts with significant scientific discoveries or observations related to human diseases, for example the discovery and analytical and preclinical validation of novel diagnostic or therapy related markers, the potential of protein profiles for the development of personalized medicine. This will include original research articles and reviews in proteomics and bioinformatics. Articles in the development and application of technologies, clinical studies, methodologies, and protocols are also welcome.

Letter to the Editor
Meeting report
Research
Review

Editor-in-Chief
Prof Daniel W Chan, Johns Hopkins University, USA
Associate Editors
Prof Tim Griffin, University of Minnesota, USA  
Dr Danni Li, University of Minnesota, USA  
Prof John G Marshall, Ryerson University, Canada 
Dr Stephen R Master, Children’s Hospital of Philadelphia, USA 
Prof Ed Nice, Ludwig Institute for Cancer Research, Australia
Prof Stephen Pennington, University College Dublin, Ireland
Dr Alex Rai, Columbia University, USA
Dr Karin Rodland, Pacific Northwest National Laboratory, USA
Prof KW Michael Siu, University of Windsor, Canada 
Dr Pothur Srinivas, National Institutes of Health, USA
Prof Hui Zhang, Johns Hopkins Medical Institutions, USA
Senior Editors
Prof Mark S Baker, Macquarie University, Australia
Prof Denis Hochstrasser, Geneva University, Switzerland 
Prof Gilbert S Omenn, University of Michigan, USA
Dr Richard D Smith, Pacific Northwest National Laboratory, USA 

Editorial Board
Prof Dr Ruedi Aebersold, ETH Zurich, Switzerland
Dr Leigh Anderson, Plasma Proteome Institute, USA
Dr Christoph Borchers, University of Victoria, Canada 
Dr Ben Collins, ETH Zurich, Switzerland
Prof Fernando Corrales, Centro Nacional de Biotecnología, Spain
Prof Catherine E Costello, Boston University, USA
Dr Mari DeMarco, University of British Columbia, Canada
Prof Eleftherios P Diamandis, University of Toronto, Canada 
Dr Andrei Drabovich, University of Alberta, Canada
Prof Rebekah Gundry, Medical College of Wisconsin, USA
Dr Brian Haab, Van Andel Institute, USA 
Prof Samir Hanash, Fred Hutchinson Cancer Research Center, USA 
Prof Fuchu He, Beijing Institute of Radiation Medicine, China 
Prof Michelle Hill, QIMR Berghofer Medical Research Institute, Australia
Dr Andrew Hoofnagle, University of Washington, USA 
Prof Connie Jimenez, VU University Medical Center, The Netherlands
Dr Jacob Kagan, National Cancer Institute, USA 
Dr Mahesh Kulkarni, CSIR-National Chemical Laboratory, India
Dr Scott Kuzdzal, Shimadzu Scientific Instruments, UK 
Prof Joshua LaBaer, Arizona State University, USA 
Prof Maggie Lam, University of Colorado, USA
Prof Qing Kay Li, Johns Hopkins Medical Institutions, USA
Prof Yan Li, Chinese Academy of Sciences, China 
Prof Joseph Loo, University of California Los Angeles, USA 
Dr Mary F Lopez, Nuclea Biotechnologies, USA
Prof Peter Luppa, Technische Universität München, Germany  
Prof Michael Moran, University of Toronto, Canada 
Prof Fumio Nomura, Chiba University, Japan 
Prof Nicolle Packer, Macquarie University, Australia
Prof Young-Ki Paik, Yonsei University, South Korea
Prof Akhilesh Pandey, Mayo Clinic, USA  
Prof Peipei Ping, University of California Los Angeles, USA 
Prof Terence CW Poon, University of Macau, China
Dr Henry Rodriguez, National Cancer Institute, USA 
Prof Michael Roehrl, Memorial Sloan Kettering Cancer Center, USA
Prof Jean-Charles Sanchez, Centre Medical Universitaire, Switzerland
Prof Jochen Schwenk, KTH Royal Institute of Technology, Sweden
Dr Richard Semba, Johns Hopkins School of Medicine, USA
Prof John Semmes, Eastern Virginia Medical School, USA
Dr Steven Skates, Harvard University, USA 
Prof Amy Skubitz, University of Minnesota, USA
Prof Michael Snyder, Stanford University, USA
Dr Sudhir Srivastava, National Institute of Health, USA 
Dr Chris Sutton, University of Bradford, UK
Prof Naoyuki Taniguchi, RIKEN Advanced Science Institute, Japan 
Prof Jennifer van Eyk, Cedars-Sinai Medical Center, USA 
Dr Timothy D Veenstra, National Institutes of Health, USA 
Prof Marc R Wilkins, University of New South Wales, Australia 
Dr Bing Zhang, Vanderbilt University, USA 
Dr Zhen Zhang, Johns Hopkins Medical Institutions, USA 
Prof Yingming Zhao, The University of Chicago, USA 
Prof Heng Zhu, Johns Hopkins University, USA